Request for Nominations of Candidates To Serve on the Breast and Cervical Cancer Early Detection and Control Advisory Committee (BCCEDCAC), 26794-26795 [2016-10421]
Download as PDF
<![CDATA[
26794
Federal Register / Vol. 81, No. 86 / Wednesday, May 4, 2016 / Notices
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than May 31, 2016.
A. Federal Reserve Bank of
Minneapolis (Jacquelyn K. Brunmeier,
Assistant Vice President) 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291:
1. Ascent Bancorp, Helena, Montana;
to become a bank holding company by
acquiring 100 percent of the voting
shares of First Security Bank of Helena,
Helena, Montana.
Board of Governors of the Federal Reserve
System, April 29, 2016.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2016–10432 Filed 5–3–16; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention announces the
following meeting of the
aforementioned committee:
Time and Date
asabaliauskas on DSK3SPTVN1PROD with NOTICES
11:00 a.m.–2:00 p.m. EDT, Wednesday,
May 25, 2016
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public. The public
is welcome to submit written comments
in advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference at the USA toll-free, dialin number, 1–866–659–0537 and the
passcode is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
VerDate Sep<11>2014
18:44 May 03, 2016
Jkt 238001
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines,
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and
will expire on September 30, 2017.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters for Discussion: The agenda for
the conference call includes: Work
Group and Subcommittee Reports; SEC
Petitions Update for the August 2016
Advisory Board Meeting; Plans for the
August 2016 Advisory Board Meeting;
and Advisory Board Correspondence.
Contact Person for More Information:
Theodore M. Katz, M.P.A., Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Rd. NE., Mailstop: E–20, Atlanta,
GA 30333, Telephone (513) 533–6800,
Toll Free 1–800–CDC–INFO, Email
ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–10420 Filed 5–3–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Health Promotion and Disease
Prevention Research Centers: Special
Interest Project Competitive
Supplements (SIPS), DP16–006, initial
review.
Summary: This document corrects a
notice that was published in the Federal
Register on April 21, 2016, Volume 81,
Number 77, page 23497. This meeting is
cancelled in its entirety.
Contact Person for More Information:
Brenda Colley Gilbert, Ph.D., M.S.P.H.,
Director, Extramural Research Program
Operations and Services, CDC, 4770
Buford Highway NE., Mailstop F–80,
Atlanta, Georgia 30341, Telephone:
(770) 488–6295, BJC4@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. 2016–10422 Filed 5–3–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Breast and
Cervical Cancer Early Detection and
Control Advisory Committee
(BCCEDCAC)
The Centers for Disease Control and
Prevention (CDC) is soliciting
E:\FR\FM\04MYN1.SGM
04MYN1
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 86 / Wednesday, May 4, 2016 / Notices
nominations for membership on the
BCCEDCAC. The committee provides
advice and guidance to the Secretary,
HHS, and the Director, CDC, regarding
the early detection and control of breast
and cervical cancer. The committee
makes recommendations regarding
national program goals and objectives;
implementation strategies; program
priorities, including surveillance,
epidemiologic investigations, education
and training, information dissemination,
professional interactions and
collaborations, and policy.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. The Secretary, HHS, acting
through the Director, CDC, shall appoint
to the advisory committee nominees
with expertise in breast cancer, cervical
cancer, medicine, public health,
behavioral science, epidemiology,
radiology, pathology, clinical medical
care, health education, and surveillance.
Two members may be representatives of
the general public with personal
experience in issues related to breast or
cervical cancer early detection and
control. Members may be invited to
serve for up to four years.
The next cycle of selection of
candidates will conclude in the Summer
of 2016, for selection of potential
nominees to replace members whose
terms will end on March 31, 2017.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of BCCEDCAC
objectives. The U.S. Department of
Health and Human Services will give
close attention to equitable geographic
distribution and to minority and female
representation so long as the
effectiveness of the Committee is not
impaired. Appointments shall be made
without discrimination on the basis of
age, race, ethnicity, gender, sexual
orientation, HIV status, disability, and
cultural, religious, or socioeconomic
status. Consideration is given to a broad
representation of geographic areas
within the U.S., with diverse
representation of both genders, ethnic
and racial minorities, and persons with
disabilities. Nominees must be U.S.
citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the
following items:
D Current curriculum vitae or resume,
including complete contact information
(name, affiliation, mailing address,
telephone numbers, fax number, email
address);
D A 150 word biography for the
nominee;
VerDate Sep<11>2014
18:44 May 03, 2016
Jkt 238001
D At least one letter of
recommendation from a person(s) not
employed by the U.S. Department of
Health and Human Services. Candidates
may submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by HHS.
Nominations should be submitted
(postmarked or received) by June 24,
2016:
D Electronic submissions: You may
submit nominations, including
attachments, electronically to
bccedcac@cdc.gov.
D Regular, Express or Overnight Mail:
Written nominations may be submitted
to the following addressee only: Ms.
Jameka Reese Blackmon, MBA, CMP
c/o BCCEDCAC Secretariat, Centers for
Disease Control and Prevention, 3719
North Peachtree Road, Building 100,
Chamblee, Georgia 30341.
Telephone and facsimile submissions
cannot be accepted.
Contact Person for More Information:
Jameka R. Blackmon, MBA, CMP,
Designated Federal Officer, National
Center for Chronic Disease Prevention
and Health Promotion, CDC, 4770
Buford Hwy. NE., Mailstop F76, Atlanta,
Georgia 30341, Telephone (770) 488–
4880; Fax (770) 488–4760; Email:
bccedcac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and the
Agency for Toxic Substances and
Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–10421 Filed 5–3–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–16–16AHI; Docket No. CDC–2016–
0041]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
26795
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project entitled ‘‘CommunityBased Organization Outcome
Monitoring Projects for CBO HIV
Prevention Services Clients’’.
DATES: Written comments must be
received on or before July 5, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2016–
0041 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
SUMMARY:
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\04MYN1.SGM
04MYN1
]]>Agencies
[Federal Register Volume 81, Number 86 (Wednesday, May 4, 2016)]
[Notices]
[Pages 26794-26795]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-10421]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Candidates To Serve on the Breast and
Cervical Cancer Early Detection and Control Advisory Committee
(BCCEDCAC)
The Centers for Disease Control and Prevention (CDC) is soliciting
[[Page 26795]]
nominations for membership on the BCCEDCAC. The committee provides
advice and guidance to the Secretary, HHS, and the Director, CDC,
regarding the early detection and control of breast and cervical
cancer. The committee makes recommendations regarding national program
goals and objectives; implementation strategies; program priorities,
including surveillance, epidemiologic investigations, education and
training, information dissemination, professional interactions and
collaborations, and policy.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of the
committee's objectives. The Secretary, HHS, acting through the
Director, CDC, shall appoint to the advisory committee nominees with
expertise in breast cancer, cervical cancer, medicine, public health,
behavioral science, epidemiology, radiology, pathology, clinical
medical care, health education, and surveillance. Two members may be
representatives of the general public with personal experience in
issues related to breast or cervical cancer early detection and
control. Members may be invited to serve for up to four years.
The next cycle of selection of candidates will conclude in the
Summer of 2016, for selection of potential nominees to replace members
whose terms will end on March 31, 2017.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of BCCEDCAC objectives. The U.S.
Department of Health and Human Services will give close attention to
equitable geographic distribution and to minority and female
representation so long as the effectiveness of the Committee is not
impaired. Appointments shall be made without discrimination on the
basis of age, race, ethnicity, gender, sexual orientation, HIV status,
disability, and cultural, religious, or socioeconomic status.
Consideration is given to a broad representation of geographic areas
within the U.S., with diverse representation of both genders, ethnic
and racial minorities, and persons with disabilities. Nominees must be
U.S. citizens, and cannot be full-time employees of the U.S.
Government.
Candidates should submit the following items:
[ssquf] Current curriculum vitae or resume, including complete
contact information (name, affiliation, mailing address, telephone
numbers, fax number, email address);
[ssquf] A 150 word biography for the nominee;
[ssquf] At least one letter of recommendation from a person(s) not
employed by the U.S. Department of Health and Human Services.
Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by HHS.
Nominations should be submitted (postmarked or received) by June
24, 2016:
[ssquf] Electronic submissions: You may submit nominations,
including attachments, electronically to bccedcac@cdc.gov.
[ssquf] Regular, Express or Overnight Mail: Written nominations may
be submitted to the following addressee only: Ms. Jameka Reese
Blackmon, MBA, CMP c/o BCCEDCAC Secretariat, Centers for Disease
Control and Prevention, 3719 North Peachtree Road, Building 100,
Chamblee, Georgia 30341.
Telephone and facsimile submissions cannot be accepted.
Contact Person for More Information: Jameka R. Blackmon, MBA, CMP,
Designated Federal Officer, National Center for Chronic Disease
Prevention and Health Promotion, CDC, 4770 Buford Hwy. NE., Mailstop
F76, Atlanta, Georgia 30341, Telephone (770) 488-4880; Fax (770) 488-
4760; Email: bccedcac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-10421 Filed 5-3-16; 8:45 am]
BILLING CODE 4163-18-P
